Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.44 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27460406 | 0.98 | AOC3 (0.48) | AOC3NPC1RAB9ACA12CA9 | |
| SCHEMBL258776 | 0.86 | AOC3 (0.54) | AOC3NPC1RAB9ACA12CA9 | |
| Hydrazine SCHEMBL8651254 | 0.84 | AOC3 (0.52) | AOC3NPC1RAB9ACA12CA9 | |
| SCHEMBL29851956 | 0.84 | AOC3 (0.52) | AOC3NPC1RAB9ACA12CA9 | |
| SCHEMBL11693547 | 0.84 | NPC1 (0.53) | AOC3NPC1RAB9ACA12CA9 | |
| Hydrochloric Acid SCHEMBL10536523 | 0.84 | AOC3 (0.52) | AOC3NPC1RAB9ACA12CA9 | |
| SCHEMBL10782311 | 0.83 | NPC1 (0.48) | AOC3NPC1RAB9ACA12CA9 | |
| SCHEMBL1920895 | 0.83 | AOC3 (0.50) | AOC3NPC1RAB9ACA12CA9 | |
| SCHEMBL18536773 | 0.82 | AOC3 (0.45) | AOC3NPC1RAB9ACA12CA9 | |
| SCHEMBL10416109 | 0.81 | AOC3 (0.54) | AOC3NPC1RAB9ACA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1353986-B1 | COLORED THERMOPLASTIC RESIN COMPOSITIONS FOR LASER WELDING, ANTHRAQUINONE COLORANTS THEREFOR AND MOLDED PRODUCT THEREFROM | DU PONT (US) | 2006-04-12 | — | — | EP | claimed |
| EP-1334148-B1 | COLORED THERMOPLASTIC RESIN COMPOSITIONS FOR LASER WELDING, COLORANTS THEREFOR OF MIXTURES OF AMINE SALTS OF ANTHRAQUINONE AND MONOAZO COMPLEX DYES, AND MOLDED PRODUCT THEREFROM | DU PONT (US) | 2006-03-15 | — | — | EP | claimed |
| EP-0518655-B1 | Solid phase peptide synthesis | ZENECA LTD (GB) | 1997-09-10 | — | — | EP | claimed |
| US-5602231-A | SOLID PHASE SYNTHESIS OF PEPTIDES CONTAINING A C-TERMINAL AZA-AMINO ACID | ZENECA LIMITED (GB) | 1997-02-11 | — | — | US | claimed |
| EP-0518655-A2 | Solid phase peptide synthesis | ZENECA LIMITED (GB) | 1992-12-16 | — | — | EP | claimed |
| US-12545683-B2 | CBP/catenin signaling pathway inhibitors and uses thereof | 3+2 PHARMA, LLC (US) | 2026-02-10 | — | — | US | disclosed |
| US-20230348476-A1 | CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOF | 3 2 PHARMA LLC (US) | 2023-11-02 | — | — | US | disclosed |
| US-11655253-B2 | CBP/catenin signaling pathway inhibitors and uses thereof | 3+2 PHARMA, LLC (US) | 2023-05-23 | — | — | US | disclosed |
| CN-115835865-A | CBP/catenin signal transmission path inhibitor and application thereof | 3+2 制药有限责任公司 | 2023-03-21 | — | — | CN | disclosed |
| EP-4117663-A1 | CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOF | 3+2 Pharma LLC (US) | 2023-01-18 | — | — | EP | disclosed |
| US-20210317123-A1 | CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOF | 3+2 PHARMA, LLC | 2021-10-14 | — | — | US | disclosed |
| WO-2021183796-A1 | CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOF | 3+2 PHARMA (US) | 2021-09-16 | — | — | WO | disclosed |
| EP-1646633-A1 | BETA-STRAND MIMETICS AND METHOD RELATING THERETO | Choongwae Pharma Corporation (KR) | 2006-04-19 | — | — | EP | disclosed |
| EP-1353986-B1 | COLORED THERMOPLASTIC RESIN COMPOSITIONS FOR LASER WELDING, ANTHRAQUINONE COLORANTS THEREFOR AND MOLDED PRODUCT THEREFROM | DU PONT (US) | 2006-04-12 | — | — | EP | disclosed |
| EP-1334148-B1 | COLORED THERMOPLASTIC RESIN COMPOSITIONS FOR LASER WELDING, COLORANTS THEREFOR OF MIXTURES OF AMINE SALTS OF ANTHRAQUINONE AND MONOAZO COMPLEX DYES, AND MOLDED PRODUCT THEREFROM | DU PONT (US) | 2006-03-15 | — | — | EP | disclosed |
| CN-1244620-C | Colored thermoplastic resin compositions for laser welding, anthraquinone colorants therefor and molded product therefrom | DU PONT (US) | 2006-03-08 | — | — | CN | disclosed |
| WO-2004108731-A1 | BETA-STRAND MIMETICS AND METHOD RELATING THERETO | CHOONGWAE PHARMA CORPORATION (KR) | 2004-12-16 | — | — | WO | disclosed |
| US-20040053331-A1 | Beta-strand mimetics and method relating thereto | CHOONGWAE PHARMA CORPORATION (KR) | 2004-03-18 | — | — | US | disclosed |
| CN-1474850-A | Colored thermoplastic resin compositions for laser welding, anthraquinone colorants therefor and molded product therefrom | ��Ļ���Ű˾ | 2004-02-11 | — | — | CN | disclosed |
| US-3984463-A | Herbicidal 2-phenyl semicarbazides | SHELL OIL COMPANY (US) | 1976-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348476-A1 | CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOF | CREBBP, CREB1, EP300 | AOC3 4804/4885NPC1 1730/4885RAB9A 2899/4885 |
| US-20040053331-A1 | Beta-strand mimetics and method relating thereto | BIRC5, BIRC7, XIAP | AOC3 4511/4885NPC1 4373/4885RAB9A 3852/4885 |
| US-12545683-B2 | CBP/catenin signaling pathway inhibitors and uses thereof | CREBBP, CREB1, CTNNB1 | AOC3 4563/4885NPC1 1535/4885RAB9A 2198/4885 |
| US-11655253-B2 | CBP/catenin signaling pathway inhibitors and uses thereof | CREBBP, CREB1, EP300 | AOC3 4804/4885NPC1 1730/4885RAB9A 2899/4885 |
| US-20210317123-A1 | CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOF | CREBBP, CREB1, EP300 | AOC3 4804/4885NPC1 1730/4885RAB9A 2899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.